Jill Sederstrom
Jill Sederstrom is a Contributing Editor
Missing Teeth Could Be Linked to Diabetes Risk
Missing teeth could be a signal that diabetes may be developing.
Empagliflozin Reduced Liver Fat in Type 2 Patients with Nonalcoholic Fatty Liver Disease
Diabetes drug empagliflozin reduces fat levels in type 2 patients, which may reduce risk of severe liver disease.
Everything Pharmacists Need to Know About DIR Reform
Everything Pharmacists Need to Know About DIR Reform
Meaningful changes to DIR fees are on the horizon—will pharmacies see an increase in reimbursements?
New Malaria Research Shows Promising Implications for Vaccine Design and Disease Prevention
Newly found antibody may help create effective vaccine against malaria.
Vaccination Rates Lower for Children with Autism and their Siblings
Parents of children with autism spectrum disorder are less likely to fully vaccinate their autistic kid or the siblings.
Oregon Sends Home Students Lacking Immunizations
On “School Exclusion Day” in Oregon kids without the required vaccines are sent home.
Targeted Vaccination Can Stop Epidemics
A study of simulated epidemics has found that targeted vaccinations is more effective than a quarantine or taking no action at all.
The Obstacles That Impede Biosimilars
The Obstacles That Impede Biosimilars
Hurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.
The New Type 2 Diabetes Technologies Pharmacists Need to Know About
The New Type 2 Diabetes Technologies Pharmacists Need to Know About
Pharmacists need to stay informed about new technologies in order to help diabetic patients take advantage.
The Winners and Losers of 340B Changes
The Winners and Losers of 340B Changes
What CMS' big changes to the 340B Drug Discount Program will mean.

Poll